SAN FRANCISCO -- A new commercially available test called T-Detect has received emergency use authorization from the FDA. The manufacturer says it has the power to tell most patients whether or not ...

The Stanford summary backs up the "rare" label with specific numbers: about one myocarditis case per 140,000 people after a ...

Sept 18 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the ...

Contrary to public concerns, receiving frequent COVID-19 booster vaccinations will not weaken the immune system, providing reassurance to vulnerable groups facing new variants. Study: No evidence of ...